DatasetName,NFX1_S(120) NFX1_S(152) NFX1_S(49) NFX1_S(50) NFX1_Y(176),NFX1_S(1095) NFX1_S(11) NFX1_S(139) NFX1_S(147) NFX1_S(34) NFX1_S(392) NFX1_T(139),NFX1_S(123) NFX1_S(142) NFX1_S(150) NFX1_S(154) NFX1_S(326) NFX1_S(90) NFX1_S(95) NFX1_T(128) NFX1_Y(1115),NFX1_S(54) NFX1_Y(54)
RM2024_Intensity D4-1___3,,,,
RB2022_4_PostEndurance,,,,
FSO2013_Ratio M/L normalized Rep3,0.5500930124588569,,0.5062975168247106,
SR2019_MCF7_Biol_repl_3,,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,,
SR2019_LM2_Biol_repl_1,,,,
RCJD2014_15min_1,,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,,
CK2022_7 16-1,,,,
NJH2025_Sub12_HIIT_Mid,,,,
AH2018_LFQ_IT_1_C,0.5464394413845032,,,
RKK2015_TNF-α/basal,,,,
JJ2018_Ratio H/M normalized pP2,0.546770087039419,,,
NJH2025_Sub12_MICT_Pre,,,,
NJH2025_Sub7_MICT_Post,,,,
DL2023_control-3,,,,
ZX2022_Control Replicate 2,,,0.5038759869798968,
HS2024_6_B_T3,,,,
JW2015_Intensity pre1,,,,
IMM2018_normalised rep. int. Empty-3,,,,
AMK2021_30R_p5,,,,
FSO2013_Ratio M/L normalized Rep1,0.5443496797402787,,0.48621259976636705,
SR2019_MDAMB231_Biol_repl_4,,,,
GF2025_P2_Sph,,,0.48919580727673634,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,,
NJH2025_Sub13_HIIT_Mid,,,,
CP2009_Ratio M/L,,,,
NJH2025_Sub7_HIIT_Post,,,,
KBE2022_Log2_Ex_44_T,,,0.4679379840811159,
DB2022_Intensity L2,,,,
TM2022_mock.4h.C,,0.41816101944397105,,
AST2020_anti-CD3.2,,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,,
HS2024_7_B_N1,,,,
FSO2013_Ratio M/L normalized Rep1___1,0.5443976612718074,,0.48660639560922647,
SAS2015_AZD/DMSO_Exp3,,,,
RM2024_Intensity D0-2___3,,,,
RM2024_Intensity D6-1,,,,
RB2022_8_RecoverySprint,,,,
RB2022_5_PreEndurance,,,0.4825999941332464,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,0.4923573795778592,
EP2017_Untreated R#4 normalized log2 ratio,0.5352716710903779,,0.5100786644426862,
WZ2023_Pu_010_30min,,,,0.5827839656841128
AS2011_Ratio H/L Proteins RNAi_2,,,,
RB2022_4_PreStrength,,,,
NJH2024_Sub4_MICT_Post,,,,
AH2018_LFQ_M_1_X,0.5610014740714998,,,
RB2022_8_RecoveryEndurance,,,,
KBE2022_Log2_Ex_14_U,,,0.4692555545410776,
FSO2013_Ratio M/L normalized Rep3___3,,,,
AH2018_TMTMS3_1_C,,,0.48728825592257696,
JJ2018_Ratio H/L normalized___1,0.5673229266600183,,,
ZQ2022_C2,,,,
RB2022_5_PreSprint,,,0.48220513934264747,
PG2020_Intensity 8h_C,,,0.4637186926173899,
AH2018_SILAC_MR_2_N,,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,,
TM2022_S2.8h.B,,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,,
RM2024_Intensity D6-1___2,,,,
NJH2025_Sub7_MICT_Mid,,,,
LY2019_P1+,,,0.4863189208635782,
AS2011_Ratio H/L Proteins Inhi_2,,,,
BS2014_Log2(Ratio H/L normalized),0.5292229726130164,,,
UK2020_HCM_2,,,,
FSO2013_Ratio H/L normalized Rep2___2,,,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5607990066088628,,0.49486816948634643,
RM2024_Intensity D4-3___3,,,,
RB2022_5_PreStrength,,,,
NJH2024_Sub4_MICT_Mid,,,,
TM2022_S2.4h.A,,,,
RB2022_5_PostStrength,,,0.5136994204953214,
GF2025_P6_Sph,,,0.4949569524767661,
RB2022_2_PreSprint,,,,
ZX2022_CB treated Replicate 3,,,0.49816278200701525,
RM2024_Intensity D6-2___3,,,,
WZ2023_Pe_025_10min,,,,0.5824862021125397
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,,
AST2020_anti-CD3+PDL2.1,,,,
KBE2022_Log2_Ex_34_U,,,0.47450398122258375,
WZ2023_Pu_005_10min,,,,0.5910576568001666
AS2011_Ratio H/L RNAi_2_1,,,,
NJH2024_Sub9_HIIT_Mid,,,,
CK2022_9 40-1,,,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,,
LG2023_GSK3α-1_intensity,,,,
WZ2023_Pu_025_30min,,,,0.5778235257614173
AH2018_SILAC_MR_2_X,,,,
HS2024_4_PD_T2,,,,
NJH2024_Sub4_HIIT_Pre,,,,
RB2022_2_RecoverySprint,,,,
AS2011_Ratio H/L Protein RNAi_1,,,,
RM2024_Intensity D2-1___2,,,,
CR2017_Ratio Replicate 1.4,0.5310236313731693,,0.4966269214792713,
FR2021_Norm.Intensity.B,,,,
RM2024_Intensity D6-2___1,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,,
RB2022_5_PostSprint,,,0.49665494129798327,
EJN2021_3_Rest_Basal,0.5366068814704776,,0.47790066586058333,
CR2017_Ratio Replicate 1.3,0.5919562954513217,,0.5016835585797037,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,,
KTGR2014_Ratio-Rapa 7 mins,,,,
AMK2021_120R_p1,,,,
AH2018_SILAC_3_X,0.5417978500827383,,,
JJ2018_Ratio M/L normalized pP3,0.5482186228166036,,,
AH2018_SILAC_M_2_N,0.5468148110587576,,0.4859507353109017,
HS2024_7_PD_T2,,,,
FSO2013_Ratio H/L normalized Rep1___1,0.5347918091876357,,0.47674104366543957,
AH2018_LFQ_1_C,0.5499002431789675,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,,
KBE2022_Log2_Ex_28_T,,,,
HS2024_3_B_N1,,,,
RM2024_Intensity D4-2___3,,,,
WZ2023_Pe_025_30min,,,,0.578809514765452
CK2022_11 40-1,,,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,,
AH2018_SILAC_2_X,0.5478515984578214,,0.48650456244582746,
MV2014_Ratio H/M normalized A2___2 (2 min),,,,
AS2011_Ratio H/L RNAi_1_2,,,,
KS2014_Intensity E15_1,,,0.4804950633945334,
FSO2013_Ratio H/L normalized Rep2,0.5545471449350858,,0.4986880446904137,
WZ2023_Pu_005_20min,,,,0.5942791378788406
NJH2024_Sub10_MICT_Post,,,,
RM2024_Intensity D2-3___1,,,,
CR2017_Ratio Replicate 1.5,0.5979128735608513,,0.5236517402610285,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,,
HS2024_7_B_T3,,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,0.4928888810104673,
AS2011_Ratio H/L RNAi_1,,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,,
AH2018_LFQ_M_1_C,0.5547091130771477,,,
NJH2025_Sub7_MICT_Pre,,,,
SR2019_SKBR3_Biol_repl_2,,,,
HS2024_9_B_T2,,,,
KTGR2014_Ratio-AA 7 mins,,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,,
HS2024_3_PD_T1,,,,
FSO2013_Ratio M/L normalized Rep3___2,,,,
SR2019_BT549_Biol_repl_3,,,0.48444164162880315,
RCJD2014_20min_mean,,,,
FR2021_Norm.Intensity.H,,,,
RB2022_2_PreStrength,,,,
DB2022_LFQ intensity L1.2,,,,
HS2024_4_B_N1,,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,,
CK2022_1 16-1,,,,
CK2022_1 200-1,,,0.49239284366318614,
PG2020_Intensity Mock_10h_D,0.5309691579972837,,0.48953169170837946,
SR2019_MCF10A_Biol_repl_2,,,,
JJ2018_Ratio M/L normalized pP2___2,,,,
HS2024_6_PD_T1,,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,,
RB2022_6_RecoveryEndurance,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.49743472832178837,,0.5338182378477536,
RCJD2014_5min_1,,,,
RM2024_Intensity D4-1___1,,,,
DL2023_24h-1,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,,
TM2022_S2.4h.C,,,,
SAS2015_PLX/AZD_Exp2,,,,
CR2017_Ratio Replicate 3.3,0.530630776945977,,0.4905060396100283,
PG2020_Intensity 2h_C,0.5110819641778388,,0.48570320520807414,
VOI2024_Veh2 di,,,,
ZX2022_CB treated Replicate 2,,,0.49979523533217474,
KBE2022_Log2_Ex_8_T,,,0.47013363136235914,
NJH2025_Sub10_MICT_Post,,,,
HS2024_6_I_T3,,,,
RN2012_L11,,,,
AS2011_Ratio H/L Normalized Inhi_2_2,,,,
IMM2018_normalised rep. int. Empty-1,,,,
HS2024_5_PD_T1,,,,
AH2018_LFQ_M_2_C,0.5619998921683764,,,
CK2022_3 40-1,,,,
RBK2021_1260T Early,,,,
NJH2024_Sub4_HIIT_Post,,,,
HS2024_4_I_T1,,,,
YA2020_Reporter_intensity_Cancer_No.5,,,0.49519365766015905,
HH2022_Reporter intensity 8,0.5584422216904288,0.38665172466274994,,
ZQ2022_N2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,,
FSO2013_Ratio H/L normalized Rep3___3,,,,
AH2018_TMTMS3_2_N,,,0.4765814337881041,
EJN2021_5_Rest_Basal,0.5335262284109691,,0.47624291135421587,
NJH2025_Sub2_HIIT_Post,,,,
NJH2025_Sub1_MICT_Post,,,,
HS2024_9_B_T1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,,
JAW2011_Ratio H/L LS2_1,,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,,
NJH2024_Sub6_HIIT_Pre,,,,
AH2018_SILAC_3_N,0.5405143034505269,,,
YA2020_Reporter_intensity_Normal_No.1,,,0.4965827879170221,
HS2024_3_B_T1,,,,
JJ2018_Ratio H/L normalized___2,,,,
RM2024_Intensity D0-2,,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,,
RB2022_7_PostStrength,,,,
RB2022_1_PostEndurance,,,0.510209519199577,
CR2017_Ratio Replicate 3,,,,
SR2019_Hs578T_Biol_repl_3,,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,,
RBK2021_1244T Early,,,,
RB2022_3_PostSprint,,,0.5068615131622263,
NJH2024_Sub13_MICT_Mid,,,,
KTGR2014_Ratio-AA 2 mins,,,,
GF2025_P7_Sph,,,0.49475144179759956,
HS2024_8_I_T3,,,,
CF2017_EOC 3,,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,,
HS2024_6_PD_T3,,,,
DL2023_12h-2,,,,
RM2024_Intensity D6-3___1,,,,
FS2019_Ctr1,,,,
WZ2023_Pu_010_20min,,,,0.5838780456754451
AS2011_Ratio H/L_3,,,,
CK2022_1 40-1,,,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,,
CK2022_8 16-1,,,,
KS2014_Intensity N3,,0.41551877929023223,,
RB2022_4_RecoveryEndurance,,,,
RB2022_5_RecoveryEndurance,,,,
JAW2011_Ratio H/L LS1a_2,,,,
NJH2024_Sub12_HIIT_Mid,,,,
AH2018_LFQ_IT_1_N,0.5467461572785474,,,
FSO2013_Ratio H/M normalized Rep2,0.5476857524190788,,0.49498470545008616,
RAM2015_Log2 A,0.5392535004706971,0.41520834273835006,0.49206318177706876,
HS2024_8_PD_T1,,,,
JJ2018_Ratio H/L normalized pP2,0.5432890644896661,,,
CF2017_OSE 27,,0.42475384231448887,,
KS2014_Intensity E15_2,,,0.4660311948112953,
BS2014_Log2(Ratio H/L protein),,,,
PG2020_Intensity 8h_A,,,,
HS2024_7_I_T1,,,,
VOI2024_Veh3 di,,,,
RKK2015_TNF-α+SC-514/basal,,,,
SR2019_JIMT1_Biol_repl_1,,,,
HW2015_Ratio H/L normalized Exp2,,,,
HS2024_3_I_N1,,,,
AH2018_SILAC_M_3_X,0.542399470856829,,,
NJH2024_Sub9_HIIT_Post,,,,
AS2011_Ratio H/L RNAi_1_3,,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,,
NJH2025_Sub1_HIIT_Pre,,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,,
NJH2024_Sub4_HIIT_Mid,,,,
VOI2024_0.1uM 2 h_1 di,,,,
KBE2022_Log2_Ex_6_T,,,,
RM2024_Intensity D4-3___1,,,,
AH2018_LFQ_4_X,0.5490197346984014,,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,,
RB2022_8_PostEndurance,,,,
NJH2025_Sub4_MICT_Mid,,,,
YP2020_Intensity C30_R1_mult_log2,,,,
AST2020_anti-CD3.1,,,,
NJH2025_Sub4_HIIT_Post,,,,
EP2017_Untreated R#4 log2 ratio,0.5373315531536351,,0.5116841223950828,
HS2024_6_B_N1,,,,
KBE2022_Log2_Ex_27_T,,,0.476220701387105,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,,
VOI2024_0.1uM 24 h_1 mono,,,,
AMK2021_120R_p5,,,,
AS2011_Ratio H/L Proteins,,,,
NJH2024_Sub7_HIIT_Post,,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.4101621961053109,,
AS2011_Ratio H/L RNAi_2_2,,,,
RB2022_7_RecoveryStrength,,,,
AH2018_SILAC_IT_3_X,0.5362478483048142,,0.4812693493964884,
JAW2011_Ratio H/L,,,,
PG2020_Intensity 10h_C,,,,
FSO2013_Ratio M/L normalized Rep2,0.5396614847798202,,0.4924715671780453,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,,
HH2022_Reporter intensity 5,0.5598494002698511,0.3709531726896492,,
SR2019_HCC1954_Biol_repl_2,,,,
CK2022_14 40-1,,,,
RB2022_6_PreSprint,,,,
NJH2025_Sub12_MICT_Mid,,,,
PG2020_Intensity 4h_D,,,0.4684609315499467,
NJH2025_Sub2_MICT_Post,,,,
AH2018_LFQ_4_C,0.5515183524765994,,,
DL2023_control-1,,,,
AR2021_ALG 10 μM,0.5751511061255691,,0.4962758434807546,
JAW2011_Ratio H/L LS2_2,,,,
AH2018_SILAC_IT_3_N,0.5352232654975551,,0.49623936314269657,
EJN2021_4_Rest_Ins,0.5394962907197739,,0.4767007084016013,
RN2012_H05,,,,
NJH2024_Sub7_HIIT_Mid,,,,
GF2025_P2_Adh,,,0.4980548550911014,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,,
RB2022_8_PostSprint,,,,
EJN2021_1_Rest_Ins,0.5373750090566584,,0.4954024365726716,
HH2022_Reporter intensity 3,0.5286822039902954,0.4371357626573015,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,,
AH2018_SILAC_IT_1_C,0.5440870863661387,,0.4974024916739109,
JW2021_After_3,,,,
GF2025_P8_Sph,,,0.49602564052390796,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,,
JJ2018_Ratio M/L normalized pP2___1,0.5326508089376246,,,
AH2018_SILAC_2_N,0.5459741339191624,,0.48520232717333095,
CK2022_11 200-1,,,0.48872102016746016,
CK2022_12 200-1,,,0.487053186185995,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,,
RM2024_Intensity D2-1___3,,,,
NJH2024_Sub1_MICT_Pre,,,,
HH2022_Reporter intensity 9,0.5488790996687725,0.42065253839266,,
WZ2023_Su_010_20min,,,,0.5863438557510614
AH2018_TMTMS2_2_N,,,0.49065428327560073,
NJH2024_Sub13_MICT_Pre,,,,
KBE2022_Log2_Ex_41_U,,,0.4699925588225915,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.42345690710668443,,
AH2018_TMTMS3_Pool,,,0.4764157816039132,
KS2014_Intensity N4,,0.41477349317210155,0.4624649102811853,
NJH2024_Sub1_HIIT_Post,,,,
MM2018_Ratio H/L replicate2,,,,
RM2024_Intensity D4-2___2,,,,
NJH2024_Sub13_HIIT_Pre,,,,
CF2017_OSE 26,,,,
CK2022_14 200-1,,,0.4921728867457027,
SR2019_Hs578T_Biol_repl_1,,,,
RB2022_7_PostSprint,,,0.5054346925330205,
TM2022_mock.4h.A,,0.41905738742432846,,
NJH2025_Sub12_HIIT_Pre,,,,
AH2018_TMTMS3_1_N,,,0.47568589207366574,
AST2020_anti-CD3+PDL2.2,,,,
PG2020_Intensity Mock_10h_A,,,0.49507075448144555,
JW2021_After_2,,,,
NJH2024_Sub2_MICT_Post,,,,
EJN2021_2_Rest_Ins,0.5314492106888823,,0.47591113898029047,
SR2019_LM2_Biol_repl_4,,,,
CP2009_Ratio H/M,,,,
JAW2011_Ratio H/L HS,,,,
CK2022_13 16-1,,,,
GF2025_P1_Adh,,,0.48740846707183016,
GF2025_P1_Sph,,,0.5021352359538342,
EJN2021_5_Ex_Basal,0.5407662552301609,,0.4727221054326381,
HS2024_7_I_T3,,,,
JJ2018_Ratio H/L normalized pP2___2,,,,
WZ2023_Pe_010_10min,,,,0.5860291532035327
CF2017_EOC 1,,,,
CK2022_3 200-1,,,0.49201414159656387,
AH2018_LFQ_IT_3_C,0.548170998833959,,0.48683244282226096,
SR2019_Hs578T_Biol_repl_2,,,,
NJH2024_Sub12_HIIT_Post,,,,
JJ2018_Ratio H/L normalized pP1___2,,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,,
NJH2024_Sub10_MICT_Mid,,,,
NJH2024_Sub13_MICT_Post,,,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5274656549232148,,,
RB2022_3_RecoverySprint,,,,
NJH2025_Sub1_HIIT_Mid,,,,
RCJD2014_20min_2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,,
HS2024_6_PD_T2,,,,
HS2024_5_B_T1,,,0.4930487263672704,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,,
DL2023_12h-3,,,,
SR2019_MDAMB231_Biol_repl_2,,,,
HS2024_3_B_T2,,,,
RB2022_6_PreStrength,,,,
CK2022_2 40-1,,,,
RB2022_1_PostSprint,,,0.5022270833143225,
CK2022_4 200-1,,,0.4899462417324312,
JW2021_Before_2,,,,
TM2022_S2.12h.A,,0.41736278373982433,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,,
CK2022_5 16-1,,,,
AR2021_ALG 1 μM,0.5601030556150801,,0.47948082513551316,
HS2024_4_B_T1,,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,,
SR2019_BT549_Biol_repl_4,,,0.48870006274598077,
EJN2021_1_Rest_Basal,0.533118193497365,,0.5026747435112571,
NJH2025_Sub8_MICT_Post,,,,
RCJD2014_5min_3,,,,
CR2017_Ratio Replicate 3.2,0.5163607653269402,,0.49142343242658193,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,,
GF2025_P7_Adh,,,0.5009675177911481,
CK2022_9 16-1,,,,
NJH2024_Sub6_HIIT_Post,,,,
AMK2021_30R_p3,,,,
AS2011_Ratio H/L Normalized RNAi_2,,,,
RM2024_Intensity D0-2___2,,,,
KS2014_Intensity pY_N4,,,,
CK2022_13 200-1,,,0.4960121129601075,
AS2011_Ratio H/L Normalized_2,,,,
PG2020_Intensity 6h_D,,,0.48569472307574024,
CK2022_16 16-1,,,,
FS2019_db/db3,,,,
CK2022_15 40-1,,,,
NJH2024_Sub9_MICT_Pre,,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,,
WZ2023_Su_005_10min,,,,0.577350170016032
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,,
KBE2022_Log2_Ex_41_T,,,0.470379184749708,
AMK2021_Ctrl_p1,,,,
AH2018_LFQ_IT_3_X,0.5477034592273433,,0.48649860888620505,
HS2024_5_PD_T3,,,,
AH2018_TMTMS3_3_X,,,0.4772896702282768,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,,
KBE2022_Log2_Ex_40_U,,,0.4723385775126163,
AH2018_LFQ_M_1_N,0.5570931907250068,,,
KBE2022_Log2_Ex_27_U,,,0.476692035498901,
HW2015_Ratio M/L normalized Exp3,,,,
RKK2015_TNF-α/IKKb(K44M),,,,
AH2018_SILAC_M_1_N,0.5536994179112329,,,
HW2015_Ratio M/L normalized Exp1,,,,
RB2022_5_RecoveryStrength,,,,
YP2020_Intensity P10_R1_mult_log2,,,,
RB2022_7_PreStrength,,,0.46721691589503045,
YA2020_Reporter_intensity_Normal_No.4,,,0.49616869526650703,
NJH2025_Sub13_HIIT_Pre,,,,
PG2020_Intensity CT_D,0.5196636360302758,,0.4900001932173954,
NJH2025_Sub9_MICT_Post,,,,
VOI2024_Veh1 mono,,,,
CK2022_12 16-1,,,,
RN2012_L13,,,,
LG2023_Control-1_intensity,,,,
RM2024_Intensity D6-3___2,,,,
KBE2022_Log2_Ex_8_U,,,0.4621091023881221,
SR2019_SKBR3_Biol_repl_3,,,,
NJH2024_Sub1_MICT_Post,,,,
HS2024_3_I_T2,,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,,
RM2024_Intensity D0-3___3,,,,
HS2024_6_I_T2,,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,,
AS2011_Ratio H/L Protein Inhi_1,,,,
FSO2013_Ratio H/M normalized Rep2___1,0.5502336511944593,,0.49811750861565457,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,,
CK2022_10 40-1,,,,
NJH2024_Sub12_HIIT_Pre,,,,
NJH2024_Sub8_MICT_Pre,,,,
RM2024_Intensity D0-1___1,,,,
LY2019_P3+,,,0.49715091362703084,
HH2022_Reporter intensity 6,0.560338996208498,0.4111678414868566,,
RB2022_2_RecoveryStrength,,,,
KTGR2014_Ratio-AA 15 mins,,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,,
KS2014_Intensity pY_N3,,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,,
LY2019_P5-,,,0.49838146065219974,
HW2015_Ratio M/L normalized Exp2,,,,
SR2019_HCC1419_Biol_repl_1,,,,
AH2018_TMTMS2_3_X,,,0.490319939749512,
GF2025_P3_Adh,,,0.4887380253214873,
SR2019_JIMT1_Biol_repl_2,,,,
AH2018_TMTMS2_1_C,,,0.48662425898465983,
RM2024_Intensity D0-1___2,,,,
LY2019_P4+,,,0.4726055863724311,
KBE2022_Log2_Ex_19_U,,,0.47063196049065,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,0.5516812682355797,,0.49398931869729545,
RB2022_4_PostStrength,,,,
LG2023_GSK3α-3_intensity,,,,
YA2020_Reporter_intensity_Cancer_No.1,,,0.4986842448994866,
AST2020_Control,,,,
JAW2011_Ratio H/L LS1a,,,,
RCJD2014_5min_mean,,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,,
NJH2025_Sub1_MICT_Mid,,,,
TM2022_S2.12h.C,,0.416016227296554,,
NJH2025_Sub9_MICT_Mid,,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,0.5300159575716666,,0.49133189958471785,
AS2011_Ratio H/L Normalized Inhi_1_2,,,,
FSO2013_Ratio M/L normalized Rep2___1,0.5396054112008168,,0.492272835266155,
LG2023_Control-2_intensity,,,,
NJH2024_Sub8_HIIT_Pre,,,,
KS2014_Intensity pY_N2,,,,
RB2022_5_RecoverySprint,,,,
RB2022_7_RecoverySprint,,,0.46757556251397087,
YA2020_Reporter_intensity_Normal_No.3,,,0.4968414269645294,
HS2024_8_B_T2,,,0.4870958530332141,
AH2018_LFQ_1_X,0.5565032255614428,,,
RM2024_Intensity D6-1___1,,,,
RCJD2014_10min_2,,,,
FR2021_Norm.Intensity.M,,,,
RM2024_Intensity D0-3___1,,,,
KS2014_Intensity N2,,0.4179244217912003,,
HH2022_Reporter intensity 1,0.5285776999356542,0.44573013143008255,,
HH2022_Reporter intensity 2,0.5273989980635129,0.4388909061579858,,
RM2024_Intensity D6-2___2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,,
RM2024_Intensity D2-3___2,,,,
YA2020_Reporter_intensity_Normal_No.5,,,0.4837386116204512,
SR2019_MCF7_Biol_repl_1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,,
HS2024_8_B_T1,,,,
NJH2025_Sub6_HIIT_Pre,,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,,
EP2017_Untreated R#2 log2 ratio,0.5351030131772353,,0.5140349648023884,
SR2019_LM2_Biol_repl_3,,,,
RB2022_4_RecoveryStrength,,,,
CR2017_Ratio Replicate 2,0.5378078607491421,,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,,
FSO2013_Ratio H/M normalized Rep3,0.559070099959033,,0.5112375815635826,
AR2021_KD 72h,0.5534931528874851,,0.5111871944631046,
MV2014_Ratio H/M normalized B2___3 (5 min),,,,
KBE2022_Log2_Ex_18_U,,,0.46709759980727267,
AS2011_Ratio H/L Inhi_1_1,,,,
NJH2024_Sub8_MICT_Post,,,,
AH2018_TMTMS3_3_C,,,0.4762368103324065,
KBE2022_Log2_Ex_9_U,,,0.46691401525846843,
AH2018_SILAC_M_3_N,0.5412972017854857,,,
KBE2022_Log2_Ex_13_T,,,0.46911027841266395,
RM2024_Intensity D0-3,,,,
SR2019_SKBR3_Biol_repl_1,,,,
PG2020_Intensity Mock_10h_C,0.5246944585062149,,0.4856775978558063,
CF2017_OSE 29,,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,,
NJH2025_Sub1_HIIT_Post,,,,
DL2023_24h-2,,,,
HS2024_7_B_N2,,,,
PG2020_Intensity 10h_A,,,,
RN2012_L12,,,,
MV2014_Ratio M/L normalized B1___3 (5 min),,,,
NJH2024_Sub8_MICT_Mid,,,,
AH2018_LFQ_IT_4_C,0.5418733284898221,,,
SAS2015_PLX/AZD_Exp1,,,,
FR2021_Norm.Intensity.A,,,,
FSO2013_Ratio H/M normalized Rep1___1,0.5345495248063659,,0.4855364843414171,
JW2015_Intensity cap2,,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,,
NJH2024_Sub6_MICT_Post,,,,
CK2022_8 40-1,,,,
RB2022_7_RecoveryEndurance,,,0.4863126101348258,
NJH2025_Sub12_HIIT_Post,,,,
EJN2021_4_Ex_Basal,0.5399751984370782,,0.4743876352035837,
TM2022_S2.12h.B,,0.4145249786432553,,
RN2012_L15,,,0.48869123541610254,
KS2014_Intensity pY_PV3,,,,
TM2022_S2.4h.B,,,,
PG2020_Intensity 4h_A,,,0.4797375254567784,
FSO2013_Ratio H/M normalized Rep2___2,,,,
TM2022_mock.4h.B,,0.41605455053228757,,
KBE2022_Log2_Ex_24_U,,,0.46980751583772107,
NJH2025_Sub13_MICT_Mid,,,,
KS2014_Intensity C3,,,0.47668787434285076,
RB2022_1_PreSprint,,,,
HS2024_4_I_N1,,,0.48330223124582716,
CK2022_7 200-1,,,0.4951513788670518,
CK2022_5 200-1,,,0.49502480807379534,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,0.49042875241297956,
FSO2013_Ratio H/L normalized Rep2___1,0.5547965256938203,,0.4989103240394479,
NJH2024_Sub10_HIIT_Mid,,,,
RB2022_2_PostEndurance,,,,
AH2018_LFQ_2_C,0.5573568156300817,,,
AH2018_SILAC_MR_1_X,,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,,
IMM2018_normalised rep. int. Empty-2,,,,
RM2024_Intensity D4-1,,,,
KBE2022_Log2_Ex_25_U,,,0.471417117678664,
AH2018_SILAC_3_C,0.5418802965293491,,,
EJN2021_5_Rest_Ins,0.5361685503694537,,0.4741797997187317,
VOI2024_0.1uM 24 h_3 di,,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,,
DB2022_LFQ intensity L2.1,,,,
FSO2013_Ratio H/M normalized Rep1,0.5319477388617516,,0.4826106570241459,
CK2022_4 16-1,,,,
AS2011_Ratio H/L,,,,
SR2019_MCF7_Biol_repl_4,,,,
EJN2021_2_Ex_Ins,0.5374736277748887,,0.5019181368483399,
AS2011_Ratio H/L Inhi_2_3,,,,
JAW2011_Ratio H/L LS1a_1,,,,
AH2018_LFQ_1_N,0.5531236288471411,,,
SAS2015_PLX/DMSO_Exp1,,,,
SFR2015_HL_log2_ratio_avg_c,,,,
JJ2018_Ratio M/L normalized pP2,0.5325509981772427,,,
NJH2024_Sub7_MICT_Mid,,,,
PG2020_Intensity 6h_B,,,0.46398280550069704,
FSO2013_Ratio H/L normalized Rep3,0.5667872129834078,,0.5176571085594633,
GRW2016_Ratio H/L normalized SILAC 2___2,,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,,
JJ2018_Ratio M/L normalized,0.526736162712644,,,
KTGR2014_Ratio-AA 30 mins,,,,
JW2021_After_1,,,,
NJH2025_Sub2_MICT_Mid,,,,
HS2024_6_B_N2,,,,
KBE2022_Log2_Ex_9_T,,,0.46681574909336576,
AH2018_SILAC_IT_2_N,0.5361075683346443,,0.4961778279710391,
AH2018_SILAC_IT_1_X,0.5378369625269721,,0.482707774494033,
HW2015_Ratio H/L normalized Exp3,,,,
HS2024_7_PD_T1,,,,
UK2020_UA_2,,,,
RM2024_Intensity D2-1___1,,,,
GF2025_P10_Sph,,,0.4982324699389259,
WZ2023_Pe_025_20min,,,,0.5868451170446165
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,,
AH2018_LFQ_2_N,0.5519900794559962,,,
HS2024_4_I_N2,,,0.4945329372528859,
AH2018_TMTMS2_3_N,,,0.4868158677754936,
RN2012_H06,,,0.49158261894998734,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,,
HS2024_4_PD_T3,,,,
WZ2023_Su_005_30min,,,,0.5845175969991407
SR2019_HCC1419_Biol_repl_4,,,,
JJ2018_Ratio H/M normalized___2,,,,
SR2019_JIMT1_Biol_repl_3,,,,
AS2011_Ratio H/L Protein,,,,
UK2020_HCM_3,,,,
NJH2024_Sub10_HIIT_Post,,,,
CR2017_Ratio Replicate 3.1,,,,
WZ2023_Su_025_10min,,,,0.5856777644269799
AH2018_LFQ_IT_4_X,0.5417512027836301,,,
CP2009_Ratio H/L,,,,
VOI2024_0.1uM 24 h_3 mono,,,,
RB2022_4_RecoverySprint,,,,
RM2024_Intensity D6-3,,,,
WZ2023_Su_005_20min,,,,0.5878196163245804
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,,
SFR2015_HL_log2_ratio_avg_a,,,0.4785995721619799,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,,
RB2022_1_PreEndurance,,,0.4793444855791106,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,,
LG2023_GSK3α-2_intensity,0.5394861490871533,,,
EP2017_Pervanadate R#1 log2 ratio,0.6134901408137947,,0.47743974559239416,
NJH2025_Sub6_HIIT_Post,,,,
RB2022_6_RecoverySprint,,,,
KS2014_Intensity,,,0.4809521005318957,
MV2014_Ratio H/M normalized A2___1 (2 min),,,,
PG2020_Intensity 8h_D,,,0.4511382545287441,
LY2019_P7+,,,0.5054969973042543,
EP2017_Untreated R#1 normalized log2 ratio,0.5494298173766328,,0.5190353856931759,
RN2012_L10,,,,
PG2020_Intensity 4h_C,,,0.4911042767698582,
EP2017_Mitotic R#3 normalized log2 ratio,0.5218834038676385,,0.530697643632711,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,,
DB2022_LFQ intensity L1,,,,
KBE2022_Log2_Ex_24_T,,,0.47049151472719497,
RB2022_8_PostStrength,,,,
AH2018_SILAC_IT_2_X,0.537549102975659,,0.4823748447876704,
HS2024_4_B_T3,,,,
NJH2024_Sub2_HIIT_Post,,,,
HS2024_8_B_N2,,,,
NJH2025_Sub8_HIIT_Pre,,,,
JJ2018_Ratio H/L normalized pP2___1,0.5433216688753493,,,
HS2024_8_I_T2,,,,
KBE2022_Log2_Ex_6_U,,,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,,
CR2017_Ratio Replicate 1.1,0.5891974942603643,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,0.4940575936257031,
MV2014_Ratio M/H normalized B3___2 (30 min),,,,
CK2022_16 200-1,,,0.4949442400558618,
VOI2024_0.1uM 2 h_3 di,,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.4697136323547221,,0.5141412616792297,
GF2025_P9_Sph,,,0.5052658454194585,
CK2022_6 200-1,,,0.49607626655326925,
NJH2024_Sub7_MICT_Post,,,,
AH2018_TMTMS3_2_X,,,0.47210877215000757,
NJH2024_Sub8_HIIT_Post,,,,
DB2022_LFQ intensity R1,,,,
JW2015_Intensity cap3,,,,
SR2019_HCC1954_Biol_repl_1,,,,
HS2024_4_I_T2,,,,
NJH2024_Sub2_MICT_Mid,,,,
VOI2024_0.1uM 2 h_2 mono,,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,,
HS2024_4_PD_T1,,,,
SAS2015_AZD/DMSO_Exp1,,,,
NJH2024_Sub1_MICT_Mid,,,,
IMM2018_normalised rep. int. CDK5L-3,,,,
HS2024_3_B_T3,,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,,
NJH2025_Sub13_MICT_Pre,,,,
SR2019_MDAMB231_Biol_repl_3,,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,,
MM2018_Ratio H/L replicate1,,,,
PG2020_Intensity 2h_D,0.5307092146243106,,0.483907337099841,
EP2017_Untreated R#3 normalized log2 ratio,0.5327266725708639,,0.4988223379126264,
MV2014_Ratio M/H normalized A3___3 (10 min),,,,
NJH2024_Sub7_HIIT_Pre,,,,
JAW2011_Ratio H/L LS2,,,,
CK2022_8 200-1,,,0.4948709282589632,
KS2014_Intensity pY_C4,,,,
CR2017_Ratio Replicate 3.5,0.5490968121976103,,0.5151451058179544,
RB2022_7_PostEndurance,,,0.48778064552261174,
NJH2025_Sub4_HIIT_Pre,,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,0.5668697798444085,,0.49275099323231164,
TM2022_mock.12h.A,,0.41359349535176626,,
JJ2018_Ratio H/L normalized pP1,0.5451477251458529,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5254933581602591,,0.48449071184451725,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,,
KS2014_Intensity pY_E5_4,,,,
RM2024_Intensity D4-3___2,,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,0.526583693102282,,0.48501946914603017,
AH2018_SILAC_2_C,0.5482839754721051,,0.4868376570550848,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,,
HS2024_7_I_N1,,,,
KBE2022_Log2_Ex_29_T,,,0.4639529116686908,
HS2024_7_I_T2,,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,,
HS2024_6_B_T2,,,,
AMK2021_45I_p5,,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,,
SAS2015_PLX/DMSO_Exp2,,,,
EJN2021_1_Ex_Basal,0.5287400532169283,,0.4987335612459888,
FR2021_Intensity.M,,,,
RB2022_2_PostSprint,,,,
AH2018_SILAC_MR_3_N,,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,,
CF2017_FTE 13,,,,
PG2020_Intensity CT_C,0.5115018262894291,,0.4914601795604989,
ZCP2016_Ratio H/L Rep 1,,,,
FS2019_db/db2,,,,
KS2014_Intensity pY_PV4,,,,
KBE2022_Log2_Ex_39_U,,,,
EP2017_Untreated R#3 log2 ratio,0.5350289328512391,,0.5009723213652776,
RB2022_2_PostStrength,,,,
AS2011_Ratio H/L Normalized_1,,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,,
CR2017_Ratio Replicate 3.4,0.54564462088793,,0.4930613641319767,
HS2024_8_PD_T2,,,,
FS2019_Ctr2,,,,
RB2022_6_PreEndurance,,,,
FR2021_Norm.Intensity.G,,,,
NJH2025_Sub9_HIIT_Post,,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,0.5526220765906839,,0.49524245762791597,
RM2024_Intensity D4-3,,,,
HS2024_8_B_N1,,,,
NJH2025_Sub10_MICT_Mid,,,,
KBE2022_Log2_Ex_15_U,,,,
AS2011_Ratio H/L Normalized Inhi_2,,,,
RKK2015_TNF-α/SC-514,,,,
RB2022_3_PreSprint,,,,
CR2017_Ratio Replicate 2.3,0.5340777497767254,,0.49553671444148834,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,,
GF2025_P4_Adh,,,0.49545019258914536,
YA2020_Reporter_intensity_Normal_No.2,,,0.4961035923490187,
YP2020_Intensity P30_R2_mult_log2,,,,
NJH2025_Sub13_MICT_Post,,,,
HS2024_4_B_N2,,,,
HS2024_3_PD_T3,,,,
AMK2021_120R_p3,,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,,
NJH2025_Sub10_HIIT_Pre,,,,
FR2021_Intensity.G,,,,
RAM2015_Log2 C,,,0.48225398297774025,
AS2011_Ratio H/L Proteins Inhi_1,,,,
FSO2013_Ratio H/M normalized Rep1___3,,,,
AH2018_LFQ_M_2_N,0.556597079969845,,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,,
KBE2022_Log2_Ex_40_T,,,0.47220266405676625,
CK2022_2 16-1,,,,
RAM2015_Log2 B,0.5346906482329449,0.41729326316320464,0.5256828481249222,
YP2020_Intensity C10_R1_mult_log2,,,,
FSO2013_Ratio M/L normalized Rep1___2,,,,
NJH2025_Sub8_MICT_Pre,,,,
EJN2021_4_Rest_Basal,0.5376343758703644,,0.4748884270894107,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,,
JJ2018_Ratio H/M normalized pP3___1,0.5583392076824041,,,
VOI2024_Veh2 mono,,,,
HS2024_6_B_T1,,,,
UK2020_HCM_5,,,,
NJH2025_Sub10_HIIT_Post,,,,
VOI2024_0.1uM 2 h_3 mono,,,,
JW2015_Intensity pre3,,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,,
DL2023_24h-3,,,,
HS2024_7_PD_T3,,,,
PG2020_Intensity Mock_10h_B,0.5113722004835218,,0.4950818221812842,
WZ2023_Su_025_30min,,,,0.5835384132974994
AH2018_LFQ_4_N,0.5597714746677267,,,
CR2017_Ratio Replicate 1.2,0.5468973792974222,,0.5021543792773779,
AS2011_Ratio H/L Normalized by Proteins,,,,
RB2022_6_RecoveryStrength,,,,
HS2024_8_I_N1,,,,
AMK2021_Ctrl_p3,,,,
AS2011_Ratio H/L Protein Inhi_2,,,,
HH2022_Reporter intensity 7,0.5575252505830586,0.3838038683098644,,
AH2018_SILAC_M_1_X,0.5556251263659101,,,
RB2022_7_PreEndurance,,,0.4889116698619278,
VOI2024_0.1uM 24 h_2 di,,,,
DL2023_control-2,,,,
LY2019_P6+,,,0.48765685097226036,
DB2022_LFQ intensity R2,,,,
GF2025_P6_Adh,,,0.48391655431945274,
VOI2024_Veh1 di,,,,
AS2011_Ratio H/L RNAi_2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,,
VOI2024_Veh3 mono,,,,
HS2024_5_I_T2,,,,
NJH2025_Sub7_HIIT_Mid,,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,,
RB2022_6_PostSprint,,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,,
AS2011_Ratio H/L Inhi_1,,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,,
AH2018_TMTMS3_2_C,,,0.4773104207565331,
SR2019_Hs578T_Biol_repl_4,,,,
RB2022_8_PreStrength,,,,
KS2014_Intensity C5,,,0.4777637685531111,
RM2024_Intensity D0-1,,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,,
YP2020_Intensity P30_R1_mult_log2,,,,
NJH2025_Sub2_HIIT_Pre,,,,
RB2022_3_RecoveryEndurance,,,0.4868891879716061,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,,
GF2025_P9_Adh,,,0.49845547921955746,
RB2022_3_PostStrength,,,0.49319012763159686,
TM2022_S2.8h.A,,,,
AS2011_Ratio H/L RNAi_1_1,,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,,
NJH2025_Sub2_MICT_Pre,,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,,
HS2024_4_B_T2,,,,
SR2019_BT549_Biol_repl_1,,,0.48362883338110024,
AH2018_LFQ_M_4_N,0.5642909934921286,,,
NJH2024_Sub8_HIIT_Mid,,,,
PG2020_Intensity 8h_B,,,0.4476948490754567,
AH2018_LFQ_2_X,0.5568725403707013,,,
PG2020_Intensity 2h_B,0.5190533010412024,,0.47538566426467393,
AS2011_Ratio H/L Proteins RNAi_1,,,,
RB2022_4_PostSprint,,,,
KS2014_Intensity E15_3,,,0.48059682183493124,
GF2025_P3_Sph,,,0.48921761480397674,
DB2022_LFQ intensity L2,,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,,
AH2018_SILAC_1_C,0.5464377000418178,,,
NJH2024_Sub1_HIIT_Pre,,,,
FSO2013_Ratio M/L normalized Rep2___2,,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.409069422680344,,
AS2011_Ratio H/L RNAi_2_3,,,,
AH2018_SILAC_IT_1_N,0.5365749877889882,,0.49618529373955866,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,,
RB2022_4_PreEndurance,,,,
JJ2018_Ratio M/L normalized pP1,0.5157123386386528,,,
CR2017_Ratio Replicate 2.4,0.597727704185211,,0.5104885174760125,
ZQ2022_N1,,,,
LY2019_P6-,,,0.496491022254433,
RM2024_Intensity D2-3,,,,
UK2020_HCM_1,,,,
JW2015_Intensity pre2,,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,,
RM2024_Intensity D2-1,,,,
NJH2025_Sub12_MICT_Post,,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,,
RN2012_L14,,,0.49733653486539553,
AH2018_LFQ_3_N,0.5581734588432068,,,
RKK2015_TNF-α/IKKb,,,,
SFR2015_HL_log2_ratio_std_b,,,0.4520682484840956,
UK2020_UA_1,,,,
KBE2022_Log2_Ex_13_U,,,0.46595557243259783,
AS2011_Ratio H/L Normalized Inhi_1,,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,,
RB2022_1_RecoverySprint,,,0.47932652690406363,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,0.5667862508444734,,0.49012104754044233,
JJ2018_Ratio H/L normalized pP3,0.5675137753838394,,,
CK2022_7 40-1,,,,
AS2011_Ratio H/L Inhi_1_3,,,,
NJH2025_Sub10_HIIT_Mid,,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,,
JAW2011_Ratio H/L LS1b_1,,,,
PG2020_Intensity 4h_B,,,0.46870224102066377,
SR2019_BT549_Biol_repl_2,,,0.48196363948553195,
RM2024_Intensity D4-2,,,,
DB2022_LFQ intensity R2.2,,,,
JJ2018_Ratio H/L normalized,0.566755139531667,,,
RB2022_5_PostEndurance,,,,
HS2024_5_PD_T2,,,,
WZ2023_Su_025_20min,,,,0.5868442951008491
RM2024_Intensity D2-2___1,,,,
IMM2018_normalised rep. int. CDK5L-2,,,,
LY2019_P8-,,,0.4949285858167063,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,0.5458207142261194,,0.49377456577683865,
FSO2013_Ratio H/L normalized Rep1,0.5319449106093983,,0.4732501057434378,
NJH2024_Sub2_HIIT_Pre,,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,0.5442321245120093,,0.49599708562322203,
CK2022_13 40-1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,,
RN2012_H02,,,,
PG2020_Intensity 10h_D,,,,
RB2022_8_PreEndurance,,,,
HS2024_3_B_N2,,,,
EJN2021_4_Ex_Ins,0.5359610965361019,,0.4759481739110524,
AS2011_Ratio H/L Normalized by Protein,,,,
EJN2021_1_Ex_Ins,0.5343197898510826,,0.4998712854430976,
EP2017_Pervanadate R#3 log2 ratio,0.5644126139681606,,0.4983817134094363,
FSO2013_Ratio M/L normalized Rep1___3,,,,
NJH2025_Sub4_HIIT_Mid,,,,
RCJD2014_5min_2,,,,
RB2022_6_PostStrength,,,,
AH2018_SILAC_MR_3_C,,,,
AH2018_LFQ_M_4_C,0.5564343563506735,,,
NJH2024_Sub4_MICT_Pre,,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,,
DL2023_12h-1,,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,,
DB2022_LFQ intensity L1.1,,,,
NJH2025_Sub6_MICT_Pre,,,,
NJH2025_Sub6_MICT_Post,,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,0.5374207339565757,,0.49122569981476416,
RN2012_H04,,,,
CK2022_6 40-1,,,,
DB2022_LFQ intensity R2.1,,,,
KBE2022_Log2_Ex_42_U,,,,
LY2019_P3-,,,0.5052065076855196,
FR2021_Intensity.A,,,,
EJN2021_3_Ex_Ins,0.5295777886268696,,0.4736019721147845,
MV2014_Ratio M/L normalized A1___1 (2 min),,,,
WZ2023_Pe_005_30min,,,,0.5806528947715208
HS2024_8_PD_T3,,,,
EJN2021_3_Ex_Basal,0.5359041710425279,,0.4728474687881816,
AST2020_Control.1,,,,
JW2015_Intensity cap1,,,,
PG2020_Intensity CT_A,0.5056040909528321,,0.4784797654921933,
FS2019_Ctr3,,,,
WZ2023_Pu_025_20min,,,,0.579649222961841
NJH2025_Sub4_MICT_Post,,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,,
GF2025_P10_Adh,,,0.49682594587590845,
RB2022_1_RecoveryStrength,,,,
SR2019_HCC1954_Biol_repl_4,,,,
FR2021_Norm.Intensity.N,,,,
HS2024_5_B_N1,,,,
FSO2013_Ratio H/M normalized Rep3___3,,,,
AH2018_TMTMS2_2_C,,,0.49312479976462065,
RB2022_4_PreSprint,,,,
DB2022_Intensity R2,,,,
AH2018_TMTMS2_Pool,,,0.4716492395057254,
HS2024_8_I_N2,,,,
RB2022_3_RecoveryStrength,,,,
NJH2024_Sub6_HIIT_Mid,,,,
AH2018_SILAC_M_1_C,0.555618460829165,,,
LY2019_P8+,,,0.5012922292163606,
RB2022_2_RecoveryEndurance,,,,
JJ2018_Ratio H/M normalized pP2___1,0.5467629011336745,,,
JAW2011_Ratio H/L HS_1,,,,
RB2022_3_PostEndurance,,,0.48971887399782926,
KS2014_Intensity pY_PV1,,,,
JAW2011_Ratio H/L LS1b_2,,,,
SR2019_MCF7_Biol_repl_2,,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.41241669119245156,,
AS2011_Ratio H/L Normalized RNAi_1_1,,,,
AH2018_LFQ_M_4_X,0.55416128195077,,,
NJH2024_Sub6_MICT_Pre,,,,
JJ2018_Ratio M/L normalized pP1___2,,,,
YP2020_Intensity C30_R2_mult_log2,,,,
NJH2024_Sub9_HIIT_Pre,,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,,
RM2024_Intensity D0-1___3,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,,
KBE2022_Log2_Ex_28_U,,,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,,
CF2017_FTE 17,,0.41627287025457665,,
LY2019_P2-,,,0.5018622296084555,
AH2018_LFQ_IT_1_X,0.5495080621296936,,,
JJ2018_Ratio H/L normalized pP3___1,0.5677837041035693,,,
RB2022_8_RecoveryStrength,,,,
WZ2023_Pe_005_20min,,,,0.5798082339241424
AST2020_Control.2,,,,
NJH2025_Sub6_MICT_Mid,,,,
RCJD2014_10min_1,,,,
FSO2013_Ratio H/L normalized Rep2___3,,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,,
HS2024_3_I_T1,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,,
CK2022_4 40-1,,,,
SR2019_MCF10A_Biol_repl_4,,,,
KS2014_Intensity pY_C5,,,,
NJH2025_Sub4_MICT_Pre,,,,
NJH2024_Sub9_MICT_Post,,,,
CF2017_OSE 28,,0.40969952241980995,,
HS2024_5_B_T2,,,0.4832733406052647,
HS2024_6_I_T1,,,,
HS2024_5_B_T3,,,,
JJ2018_Ratio H/M normalized pP1___1,0.564300924564087,,,
KBE2022_Log2_Ex_36_U,,,0.4720265271328041,
AH2018_TMTMS3_3_N,,,0.47178076725094886,
SR2019_HCC1419_Biol_repl_2,,,,
FR2021_Intensity.N,,,,
AS2011_Ratio H/L Inhi_2_1,,,,
AH2018_SILAC_MR_1_C,,,,
NJH2024_Sub1_HIIT_Mid,,,,
NJH2025_Sub8_HIIT_Mid,,,,
EP2017_Mitotic R#3 log2 ratio,0.5300560438174697,,0.5402648013750757,
KBE2022_Log2_Ex_36_T,,,0.4737240700227644,
NJH2025_Sub6_HIIT_Mid,,,,
WZ2023_Pu_005_30min,,,,0.5926956256722772
KS2014_Intensity C2,,,0.47931710165508373,
FSO2013_Ratio H/L normalized Rep1___2,,,,
RM2024_Intensity D2-2,,,,
KBE2022_Log2_Ex_42_T,,,,
CK2022_9 200-1,,,0.49003962381463295,
GRW2016_Ratio H/L normalized SILAC 2___1,,,,
JJ2018_Ratio H/M normalized pP3___2,,,,
DB2022_LFQ intensity R1.1,,,,
CK2022_10 200-1,,,0.49087868933078066,
NJH2024_Sub9_MICT_Mid,,,,
JAW2011_Ratio H/L_2,,,,
HS2024_7_I_N2,,,0.4899196080561411,
RBK2021_1332T Late,,,,
LY2019_P1-,,,0.5048040614361352,
RKK2015_TNF-α/basal.1,,,,
RKK2015_TNF-α/TNF-α+SC-514,,,,
CR2017_Ratio Replicate 2.5,0.6161491351833775,,0.4958414360749587,
HS2024_3_I_T3,,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,0.5508214229315342,,0.49195222983713754,
AS2011_Ratio H/L Normalized RNAi_1,,,,
KS2014_Intensity E15_4,,,,
ZQ2022_C3,,,,
EJN2021_3_Rest_Ins,0.5371446488515814,,0.47136200816739,
YP2020_Intensity P10_R2_mult_log2,,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,,
NJH2025_Sub1_MICT_Pre,,,,
KBE2022_Log2_Ex_39_T,,,,
FSO2013_Ratio H/M normalized Rep3___2,,,,
RM2024_Intensity D6-2,,,,
EP2017_Untreated R#1 log2 ratio,0.5519249491796385,,0.5210114885493973,
RKK2015_SC-514/basal,,,,
RM2024_Intensity D6-1___3,,,,
WZ2023_Pu_010_10min,,,,0.58399176147243
NJH2025_Sub9_HIIT_Mid,,,,
SR2019_SKBR3_Biol_repl_4,,,,
HS2024_5_I_T3,,,,
KS2014_Intensity N1,,0.4137394783365554,0.4734614250583912,
NJH2024_Sub12_MICT_Post,,,,
TM2022_S2.8h.C,,,,
CR2017_Ratio Replicate 1,0.5478061959120988,,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,0.491307710255764,
JJ2018_Ratio H/M normalized pP3,0.5582311963811447,,,
AH2018_SILAC_MR_2_C,,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,,
PG2020_Intensity 2h_A,,,0.47628646628603427,
NJH2024_Sub6_MICT_Mid,,,,
NJH2025_Sub13_HIIT_Post,,,,
AH2018_SILAC_MR_3_X,,,,
JJ2018_Ratio H/M normalized___1,0.5847296315019965,,,
RCJD2014_15min_2,,,,
AS2011_Ratio H/L_2,,,,
AS2011_Ratio H/L Normalized,,,,
RN2012_H03,,,,
HS2024_5_B_N2,,,,
HS2024_5_I_N1,,,,
HS2024_6_I_N1,,,,
AR2021_KD 48h,0.5577108912621005,,0.4672063886413587,
FR2021_Intensity.B,,,,
RB2022_3_PreEndurance,,,0.46721858216009277,
HS2024_5_I_T1,,,,
NJH2024_Sub10_MICT_Pre,,,,
SR2019_LM2_Biol_repl_2,,,,
AST2020_anti-CD3,,,,
SR2019_MDAMB231_Biol_repl_1,,,,
RM2024_Intensity D2-3___3,,,,
WZ2023_Pe_005_10min,,,,0.5778115771218792
KBE2022_Log2_Ex_29_U,,,0.46534858888920255,
HS2024_7_B_T1,,,,
AH2018_LFQ_M_2_X,0.5618951810133616,,,
AH2018_LFQ_IT_4_N,0.5404865174884425,,,
CK2022_15 200-1,,,0.49407826044899283,
RM2024_Intensity D4-1___2,,,,
JJ2018_Ratio H/M normalized,0.5844783511297007,,,
JJ2018_Ratio M/L normalized pP3___1,0.5482537922793529,,,
KBE2022_Log2_Ex_34_T,,,0.4726892223662158,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,0.5412359922299514,,0.4957254069161835,
LY2019_P2+,,,0.4885480795798319,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,,
CK2022_2 200-1,,,0.49507954564916123,
AS2011_Ratio H/L Protein RNAi_2,,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,,
WZ2023_Su_010_30min,,,,0.5853585653910531
RN2012_H01,,,,
KTGR2014_Ratio-Rapa 2 mins,,,,
EJN2021_2_Rest_Basal,0.537005993581812,,0.4749975697288,
KS2014_Intensity pY_E5_3,,,,
MM2018_Ratio H/L replicate 3,,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6112057989008137,,0.47439059298662833,
HS2024_8_B_T3,,,,
YA2020_Reporter_intensity_Cancer_No.3,,,0.49500933791963103,
KBE2022_Log2_Ex_44_U,,,0.4701918303466244,
WZ2023_Pe_010_20min,,,,0.5824480358784543
KS2014_Intensity pY_C6,,,,
AS2011_Ratio H/L Normalized_3,,,,
RCJD2014_15min_mean,,,,
RB2022_3_PreStrength,,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,,
RCJD2014_10min_mean,,,,
KS2014_Intensity C1,,,0.4827876191211009,
FSO2013_Ratio H/M normalized Rep3___1,0.5591299863795663,,0.5112435329679146,
AH2018_SILAC_M_3_C,0.5425243135151743,,,
RKK2015_TNF-α+IKKb/TNF-α,,,,
RM2024_Intensity D0-3___2,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,,
AH2018_SILAC_M_2_C,0.5490100944834579,,0.48743475315208823,
AH2018_SILAC_M_2_X,0.5466338445371102,,0.48602164412532656,
KTGR2014_Ratio-Rapa 15 mins,,,,
RM2024_Intensity D4-2___1,,,,
KBE2022_Log2_Ex_15_T,,,,
VOI2024_0.1uM 24 h_1 di,,,,
WZ2023_Su_010_10min,,,,0.5808228229642668
PG2020_Intensity 6h_C,,,0.47638011955758397,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,,
JJ2018_Ratio M/L normalized pP1___1,0.5150668867742811,,,
AH2018_LFQ_M_3_N,0.5628587053655452,,,
VOI2024_0.1uM 24 h_2 mono,,,,
AH2018_TMTMS2_3_C,,,0.48694092979757464,
CK2022_15 16-1,,,,
CK2022_3 16-1,,,,
LY2019_P4-,,,0.4861048313282999,
FSO2013_Ratio H/L normalized Rep3___2,,,,
KS2014_Intensity pY_PV2,,,,
HS2024_3_I_N2,,,,
GF2025_P8_Adh,,,0.49024584718179187,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,,
GF2025_P5_Sph,,,0.48966969093952645,
CK2022_10 16-1,,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,,
VOI2024_0.1uM 2 h_2 di,,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.42233999865282085,,
NJH2024_Sub2_HIIT_Mid,,,,
AMK2021_45I_p3,,,,
NJH2024_Sub13_HIIT_Mid,,,,
DB2022_LFQ intensity R1.2,,,,
DB2022_Intensity R1,,,,
NJH2024_Sub12_MICT_Mid,,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,,
UK2020_HCM_4,,,,
SAS2015_AZD/DMSO_Exp2,,,,
IMM2018_normalised rep. int. CDK5L-1,,,,
DB2022_LFQ intensity L2.2,,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,,
EP2017_Mitotic R#1 log2 ratio,0.4819136343956722,,0.5226016980699673,
EJN2021_2_Ex_Basal,0.5332070164544374,,0.5012945645157605,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,,
KTGR2014_Ratio-Rapa 30 mins,,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,0.5502815158833823,,,
CF2017_FTE 16,,0.4221157207085619,,
AR2021_L41 10 μM,0.584763280253903,,0.491595924227598,
CF2017_EOC 2,,,,
RB2022_6_PostEndurance,,,,
AH2018_SILAC_1_N,0.5467298309376402,,,
NJH2024_Sub10_HIIT_Pre,,,,
AS2011_Ratio H/L Inhi_1_2,,,,
UK2020_HCM_6,,,,
RB2022_7_PreSprint,,,,
NJH2024_Sub2_MICT_Pre,,,,
HS2024_3_PD_T2,,,,
CK2022_6 16-1,,,,
ZX2022_CB treated Replicate 1,,,0.500963948977761,
BS2014_Log2(Ratio H/L normalized Rep_3),0.5287061083653715,,,
TM2022_mock.12h.C,,0.41273912993719747,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,,
HH2022_Reporter intensity 0,0.5294889004215558,0.44665218863681133,,
RM2024_Intensity D2-2___2,,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,,
RB2022_1_PreStrength,,,,
JJ2018_Ratio H/M normalized pP2___2,,,,
AH2018_TMTMS2_2_X,,,0.4823411248343839,
AR2021_L41 1 μM,0.5710852670264368,,0.4931528073522649,
JJ2018_Ratio H/M normalized pP1___2,,,,
AH2018_TMTMS2_1_N,,,0.48674876434578934,
NJH2025_Sub10_MICT_Pre,,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,,
ZX2022_Control Replicate 3,,,0.5010075302218922,
KS2014_Intensity C4,,,0.4672869498048121,
AS2011_Ratio H/L Inhi_2,,,,
KBE2022_Log2_Ex_18_T,,,0.46426038333034003,
NJH2025_Sub9_MICT_Pre,,,,
RCJD2014_20min_1,,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,,
FSO2013_Ratio M/L normalized Rep2___3,,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,,
SR2019_MCF10A_Biol_repl_3,,,,
HS2024_7_B_T2,,,,
SAS2015_PLX/DMSO_Exp3,,,,
AMK2021_Ctrl_p5,,,,
NJH2025_Sub2_HIIT_Mid,,,,
AH2018_LFQ_M_3_C,0.5582964846747946,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,0.5315244767382532,,0.49425775318969833,
YA2020_Reporter_intensity_Cancer_No.2,,,0.4954834028672438,
FSO2013_Ratio H/M normalized Rep2___3,,,,
RB2022_8_PreSprint,,,,
AH2018_SILAC_IT_3_C,0.5428560340740609,,0.4973878544308902,
WZ2023_Pu_025_10min,,,,0.5889101021798769
RM2024_Intensity D2-2___3,,,,
AS2011_Ratio H/L_1,,,,
RCJD2014_10min_3,,,,
FSO2013_Ratio M/L normalized Rep3___1,0.549642838966031,,0.5056978127830629,
SR2019_JIMT1_Biol_repl_4,,,,
YP2020_Intensity C10_R2_mult_log2,,,,
ZCP2016_Ratio H/L Rep 2,,,,
CF2017_EOC 4,,,,
JJ2018_Ratio H/L normalized pP1___1,0.5411352713512378,,,
WZ2023_Pe_010_30min,,,,0.5860502267806292
MV2014_Ratio L/M normalized B2___3 (30 min),,,,
AH2018_LFQ_IT_3_N,0.5458337089455981,,0.4851860531910218,
KS2014_Intensity C6,,,0.4760571871566452,
ZQ2022_N3,,,,
HW2015_Ratio H/L normalized Exp1,,,,
CK2022_12 40-1,,,,
NJH2024_Sub7_MICT_Pre,,,,
ZX2022_Control Replicate 1,,,0.5074989538764679,
JJ2018_Ratio H/M normalized pP1,0.5645917551347074,,,
CK2022_16 40-1,,,,
AH2018_SILAC_IT_2_C,0.5453818067943889,,0.4973802853990919,
CK2022_5 40-1,,,,
AH2018_LFQ_3_X,0.5556386805830028,,,
UK2020_UA_3,,,,
LY2019_P7-,,,0.5022310603966612,
GF2025_P5_Adh,,,0.4964214454220619,
RB2022_1_PostStrength,,,0.47842987735249337,
JAW2011_Ratio H/L LS1b,,,,
FSO2013_Ratio H/L normalized Rep3___1,0.5672596395723185,,0.5181167895265751,
SR2019_HCC1954_Biol_repl_3,,,,
CR2017_Ratio Replicate 2.2,0.5563774794723242,,0.532265680365807,
VOI2024_0.1uM 2 h_1 mono,,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,,
CK2022_11 16-1,,,,
ZQ2022_C1,,,,
CR2017_Ratio Replicate 2.1,0.5203883819145696,,,
PG2020_Intensity CT_B,0.5200497228059459,,0.48840890549459826,
JJ2018_Ratio M/L normalized___2,,,,
AH2018_SILAC_MR_1_N,,,,
KS2014_Intensity pY_E5_1,,,,
JW2021_Before_3,,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,,
FS2019_db/db1,,,,
NJH2025_Sub9_HIIT_Pre,,,,
JAW2011_Ratio H/L_1,,,,
RCJD2014_20min_3,,,,
AH2018_LFQ_3_C,0.5534689550476595,,,
JJ2018_Ratio M/L normalized pP3___2,,,,
AMK2021_45I_p1,,,,
NJH2025_Sub8_HIIT_Post,,,,
AH2018_LFQ_M_3_X,0.5602844165711357,,,
YA2020_Reporter_intensity_Cancer_No.4,,,0.49408591840700045,
KS2014_Intensity pY_E5_2,,,,
FSO2013_Ratio H/L normalized Rep1___3,,,,
GF2025_P4_Sph,,,0.4899135143911406,
RB2022_2_PreEndurance,,,,
JW2021_Before_1,,,,
KBE2022_Log2_Ex_25_T,,,0.472444027228355,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,,
JJ2018_Ratio M/L normalized___1,0.5265549026700931,,,
FR2021_Intensity.H,,,,
CK2022_14 16-1,,,,
AST2020_anti-CD3+PDL2,,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,,
KBE2022_Log2_Ex_19_T,,,0.4652358478653812,
KS2014_Intensity pY_N1,,,,
RB2022_1_RecoveryEndurance,,,,
FSO2013_Ratio H/M normalized Rep1___2,,,,
HS2024_8_I_T1,,,0.4889598825906232,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,,
EP2017_Mitotic R#2 log2 ratio,0.5070128598573594,,0.5417224860566701,
AH2018_TMTMS2_1_X,,,0.48764940546783264,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,,
ZCP2016_Ratio H/L Rep 3,,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,,
SR2019_MCF10A_Biol_repl_1,,,,
NJH2025_Sub8_MICT_Mid,,,,
EJN2021_5_Ex_Ins,0.5410353028990613,,0.47373367496264635,
HS2024_6_I_N2,,,,
HH2022_Reporter intensity 4,0.5543241868283684,0.41325229705126215,,
RBK2021_1326T Late,,,,
TM2022_mock.12h.B,,0.410368296352007,,
NJH2024_Sub12_MICT_Pre,,,,
RCJD2014_15min_3,,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,,
LG2023_Control-3_intensity,,,,
JJ2018_Ratio H/L normalized pP3___2,,,,
CF2017_FTE 15,,0.41683160809782166,,
HS2024_4_I_T3,,,,
AH2018_SILAC_1_X,0.5494666844757969,,,
PG2020_Intensity 10h_B,,,,
AH2018_TMTMS3_1_X,,,0.4759061475711349,
CF2017_FTE 14,,0.4032606950898751,,
NJH2024_Sub13_HIIT_Post,,,,
RM2024_Intensity D6-3___3,,,,
NJH2025_Sub7_HIIT_Pre,,,,
RBK2021_1259T Early,,,,
RKK2015_IKK+TNF-α/IKKb,,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,,
PG2020_Intensity 6h_A,,,0.4854207754622773,
SR2019_HCC1419_Biol_repl_3,,,,
KBE2022_Log2_Ex_14_T,,,0.4676446280386656,
EP2017_Untreated R#2 normalized log2 ratio,0.5330351817480469,,0.5122521540486953,
RM2024_Intensity D0-2___1,,,,
DB2022_Intensity L1,,,,
LY2019_P5+,,,0.4729943104245707,
HS2024_5_I_N2,,,,
SAS2015_PLX/AZD_Exp3,,,,
EP2017_Pervanadate R#2 log2 ratio,0.5295411242430325,,0.4884400295290346,
AS2011_Ratio H/L Normalized RNAi_2_1,,,,
